本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Orchestra BioMed

2.97
+0.440017.39%
盤後2.980.0103+0.35%16:02 EDT
成交量:78.33萬
成交額:223.92萬
市值:1.14億
市盈率:-1.79
高:3.03
開:2.62
低:2.58
收:2.53
資料載入中...
2025/04/29

重要事件披露

Form 8-K - Current report
2025/04/01

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/03

重要事件披露

Form 8-K - Current report
2025/02/26

重要事件披露

Form 8-K - Current report
2025/02/20

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/05

重要事件披露

Form 8-K - Current report
2024/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/12

重要事件披露

Form 8-K - Current report
2024/08/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/07

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/07/30

重要事件披露

Form 8-K - Current report